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Neuritin (Nrn1) is a neurotrophin that plays an important role in nervous system plasticity and
repair following nerve injury. MicroRNAs (miRNAs) are a type of small non-coding RNA that regulate
nearly all aspects of nerve development and survival, including apoptosis. Here it was found that
miR-204 negatively regulates Nrn1 protein expression through direct interaction with Nrn1
transcript. Moreover, miR-204 activates cleaved caspase-3, enhancing the sensitivity of RSC96
Schwann cells to H2O2-induced oxidative stress and apoptosis. Thus, miR-204 expressed at a low
level may create a microenvironment suitable for the repair of injured nerves by relieving the
inhibition of Nrn1 transcription and stimulating the anti-apoptotic function of Schwann cells. These
results provide novel insights into the roles of miR-204 in nerve injury and repair.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Ischemic cerebrovascular disease is characterized by the partial
injury of neurons resulting from the disturbance of blood ﬂow in
the central nervous system (CNS), and has high incidence, mortal-
ity, and disability rates and is associated with multiple complica-
tions. Upon reduction or loss of blood ﬂow to the brain, ATP
levels and energy storage decrease, inducing ionic disorders and
dysmetabolism and resulting in neuronal injury or death. Thus,
disease outcome mostly depends on the capacity for regenerative
repair, which involves preventing the degeneration or apoptosis
of neurons, and promoting the growth of neurites and nerve
branches. Neurotrophins play an important role in both processes
[1–3]. Schwann cells are glial cells in the CNS and peripheral ner-
vous system (PNS) that play a key role in the self-repair of nerves
with their ability to dedifferentiate, proliferate, migrate, produce
growth-promoting factors, and stimulate axon regeneration. As
such, Schwann cells have been used for the repair injured periph-
eral nerves, and preliminary studies have suggested Schwann cell
transplantation as a promising strategy for CNS repair, withpromising results obtained in the regrowth and myelination of
injured CNS axons [4]. Because of the limited effectiveness of
PNS Schwann cell transplantation in CNS repair, CNS-derived
Schwann cells are more promising targets for therapeutic
interventions in CNS injury [5,6]. Schwann cells are essential for
the maintenance of healthy axons, and provide a suitable microen-
vironment for nerve regeneration by producing neurotrophins
such as nerve growth factor (NGF), brain-derived neurotrophic fac-
tor (BDNF), ciliary neurotrophic factor, neurotrophin-3 (NT-3), and
neuritin (Nrn) 1.
Candidate plasticity-related gene 15 was ﬁrst cloned from the
cDNA library of rat dentate gyrus [7,8]; after it was found to pro-
mote the rapid growth of neurites, it was also named neuritin
(Nrn) 1 [9]. Nrn1 is expressed during embryonic development,
but only the postnatal expression is implicated in activity-
dependent plasticity [10,11]. Kainic acid [9], adaptation to light
stimulation [7], synaptic activity [12], BDNF [13], NGF [14], glial
cell line-derived neurotrophic factor [15], androgen [16], and stim-
ulants [17] also can induce Nrn1 expression. Functional studies
have shown that Nrn1 overexpression can not only promote neu-
rite growth [18,19] and synapse maturation [9,20], but can also
inhibit apoptosis of neurons [21] and glia [22]. After cerebral ische-
mic reperfusion injury, Nrn1 expression is upregulated [23], which
is positively correlated with recovery index, implying that Nrn
modulates the repair of injured nerves. These results suggest that
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by preventing apoptosis and promoting neurite growth, thereby
providing a substrate for neuronal regeneration and repair. How-
ever, few studies have investigated the regulatory mechanisms
governing Nrn1 expression.
MicroRNAs (miRNAs) are small endogenous non-coding RNAs
with sizes ranging from 18 to 26 nucleotides. By binding to the
30 untranslated region (UTR) of target mRNAs, miRNAs induce their
degradation or inhibit their translation, thereby serving as post-
transcriptional regulators of gene expression [24,25]. Around 70%
of known miRNAs are expressed in the mammalian brain [26],
and these are associated with development and differentiation
[27], neurite growth [28], and synaptic plasticity [29]; as such, dys-
regulation of miRNAs can lead to various nervous system disorders.
For instance, miRNAs have been implicated in ischemic cerebro-
vascular disease [30] but also nerve repair after injury [31], imply-
ing that the occurrence and progression of cerebrovascular
diseases are linked to gene regulation by miRNAs.
This study investigated the role of miRNAs in the regulation of
Nrn1. MiR-204 was shown to inhibit Nrn1 protein expression by
binding to the 30UTR of the Nrn1 mRNA transcript. Moreover,
miR-204 increased the sensitivity of Schwann cells to oxidative
stress and induced their apoptosis via regulation of Nrn1
expression.
2. Materials and methods
2.1. Animals
Female and male Sprague–Dawley rats (n = 16 each; 8–9 weeks
old and 200–300 g) were supplied by the Xinjiang Center for
Disease Control and Prevention. Animals were divided into sham-
operated control (n = 8) and transient global ischemia (TGI) groups,
the latter with four subgroups of 6 animals each. All animals were
carried out in strict accordance with the Guidelines for the Care
and Use of Laboratory Animals by Science & Technology Depart-
ment, Hubei Province, China.
2.2. TGI model
TGI was performed as previously described [32]. Animals were
anesthetized with 10% chloral hydrate (3–4 ml/kg), and after mak-
ing median neck incisions, TGI was established by double occlusion
of the common carotid arteries for 15 min; the knot was then
removed to restore cerebral blood. Sham-operated animals were
treated identically, except for the occlusion of both CCAs. Rats in
the sham group were sacriﬁced 7 days after the surgery, while
those in the TGI groups were sacriﬁced 3, 7, 14, or 21 days after
the surgery. Tissue from the cerebral cortex and hippocampus
were dissected within 20 min and immediately stored in liquid
nitrogen for small RNA deep sequencing, Western blotting, and
quantitative real time PCR.
2.3. Small RNA deep sequencing of hippocampal tissue
Total RNA from rat hippocampus from sham (n = 4) and TGI
(n = 1 per group) rats were extracted and used for deep sequencing
based on the respective small RNA transcriptome libraries, which
was performed at the Beijing Genomics Institute, where bioinfor-
matics and microRNA proﬁling analyses were also carried out.
2.4. Analysis of Nrn1 regulatory miRNAs
TargetScan, Pictar, and miRanda algorithms were used to pre-
dict miRNAs that potentially regulate the Nrn1 gene. MiRNAs thatwere differentially expressed from the prediction were selected for
further analysis.
2.5. Cell culture
HeLa and RSC96 Schwann cells were seeded in Dulbecco’s Mod-
iﬁed Eagle’s Medium (DMEM) containing 25 mmol/l glucose and
10% fetal bovine serum (Invitrogen, Carlsbad, CA, USA).
2.6. Plasmid construction
For psiCHECK2-Nrn1–30UTR plasmid construction, the Nrn1
30UTR DNA fragment containing miR-204 and -758 binding sites
was ampliﬁed using primers Nrn1–30UTR-F, 50-CCG CTC GAG ACC
TTA AGT CCG TCT TCA CAC-30 and Nrn1–30UTR-R, 50-ATT TGC
GGC CGC TCA AGG CTC TTT TAT GTC-30 and inserted between XhoI
and NotI restriction sites of the dual-luciferase reporter vector psi-
CHECK2 (Promega, Madison, WI, USA).
The Nrn1 overexpression plasmid was generated by inserting
the Nrn1 coding sequence between the NheI and XhoI restriction
sites of the pcDNA3.1(+) vector (Clontech, Mountain, CA, USA).
The primers used for ampliﬁcation were Nrn1-NheI-F, 50-CTA
GCT AGC ATG GGA CTT AAG TTG AAC GGC-30 and Nrn1-Xho1-R,
50-CCG CTC GAG TCA GAA GGA AAG CCA GGT CGC-30 and the
PCR conditions were as follows: 94 C for 5 min, followed by 40
cycles of 94 C for 30 s, 58 C for 30 s, and 72 C for 30 s.
2.7. Cell transfection and luciferase reporter assay
HeLa cells were seeded in 24-well plates (1  105 cells/well)
and cotransfected 24 h later with psiCHECK2-Nrn1–30UTR and
either miR-204 or -758 mimics or a negative control mimic (Gene-
Pharma, Shanghai, China) using Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s protocol. After 48 h, cells were
lysed and the luciferase activity was measured using a Dual-Lucif-
erase reporter assay system (Promega) according to the manufac-
turer’s instructions. RSC96 cells were transfected with miRNA
mimics or inhibitor and collected 72 h later for analysis by quanti-
tative RT-PCR and Western blotting.
2.8. Quantitative RT-PCR
Total RNA was isolated from tissue and cells using TRIzol
reagent (Invitrogen), and cDNA was synthesized using M-MLV
reverse transcriptase (Promega) according to the supplier’s proto-
col. FastStart DNA Master SYBR Green I kit (Roche Diagnostics,
Indianapolis, IN, USA) was used to amplify Nrn1 and mature miR-
204 under the same conditions as described above (Section 2.6).
The mRNA and miRNA expression levels were normalized to those
of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and U6
small nuclear RNA (snRNA), respectively. Forward and reverse pri-
mer sets were as follows: Nrn1-F, 50-AGG GCC TGG ACG ACA AGA
CGA AC-30 and Nrn1-R, 50-CGA TTT CCG GGA GCA TGG AG-30; and
GAPDH forward, 50-CAG TGC CAG CCT CGT CTC AT-30 and GAPDH
reverse, 50-AGG GGC CAT CCA CAG TCT TC-30. Primers for reverse
transcribing mature miR-204 and U6 snRNA were designed accord-
ing to the stem-loop RT-PCR method [33] and were as follows:
miR-204-RT, 50-GTC GTA TCC AGT GCA GGG TCC GAG GTA TTC
GCA CTG GAT ACG ACA GGC ATA G-30; miR-758-RT, 50-GTC GTA
TCC AGT GCA GGG TCC GAG GTA TTC GCA CTG GAT ACA GGT
TAG TG-30; and U6-RT, 50-GTC GTA TCC AGT GCA GGG TCC GAG
GTA TTC GCA CTG GAT ACG ACA AAA TAT GGA A-30. The following
primers for used for RT-PCR: miR-204-Forward, 50-GCC CGT TCC
CTT TGT CAT C-30; miR-758-Forward, 50-GCC CGT TTG TGA CCT
GGT C-30; and U6-Forward, 50-GAC ACG CAA ATT CGT GAA
Table 1
MiRNAs that matched the conditions for candidates predicted by bioinformatics
approaches and that were differential expressed in TGI and control animals.
No miRNA miRanda TargetScan PicTar Solexa
1# rno-mir-204 ++ ++ ++ +(;)
2# rno-mir-758 ++ + ++ +(")
3 rno-mir-25-3p + + ++ 
4 rno-mir-29c-3p ++ + ++ +
5 rno-mir-34a ++ ++ + +
6 rno-mir-99a-3p ++ + ++ ++
7 rno-mir-125a-3p ++ + ++ +
8 rno-mir-134 ++ + ++ +++
9 rno-mir-182 ++ ++ ++ +++
10 rno-mir-207 ++ + ++ 
11 rno-mir-211 ++ + ++ 
12 rno-mir-223 + + ++ 
13 rno-mir-266-3p ++ ++ ++ 
14 rno-mir-323-3p ++ ++ ++ +
15 rno-mir-328 ++ + ++ +
16 rno-mir-346 ++ ++ + 
17 rno-mir-383 ++ + ++ +++
18 rno-mir-667 ++ + ++ +
19 rno-mir-761 + + ++ 
20 rno-mir-1224 ++ ++ ++ ++
+, miRNA predicted to effectively bind to the 30 UTR of the Nrn1 transcript, or
obtained by Solexa sequencing; degree of binding or number of obtained reads is
represented by the number of ‘+’ (+, common binding or number of reads between 1
and 1000; ++, predominant binding or number of reads between 1000 and 10000;
+++, number of reads > 10000; , 0).
;", Expression of TGI group decreased or increased, respectively, relative to the
sham control group.
#MiRNAs selected for experimental analysis.
MiRNA/miR, microRNA; Nrn1, neuritin 1, TGI, transient global ischemia, UTR,
untranslated region.
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GGG TCC GAG-30. Ampliﬁcation conditions were the same as above.
2.9. Western blotting
Cortical and hippocampal tissue ﬂash frozen in liquid nitrogen
was ground, mixed with RIPA lysis buffer containing proteinase
inhibitor for 30 min on an ice bath, and centrifuged at 12000g
for 10 min. Transfected RSC96 cells were collected after 72 h, lysed
in RIPA lysis buffer, and incubated for 30 min on ice, then centri-
fuged at 12000g for 10 min. The protein concentration in the
supernatants from tissue and cell lysates was determined, and
100 lg total protein was resolved by 12% SDS–PAGE and trans-
ferred to a 0.2 lm polyvinylidene diﬂuoride membrane (Millipore,
Danvers, MA, USA), which was probed with the following primary
antibodies: mouse monoclonal anti-Nrn1 (1:200; R&D Systems,
Minneapolis, MN, USA), rabbit polyclonal anti-cleaved caspase 3
(1:1000; Cell Signaling Technology, Danvers, MA, USA), and mouse
monoclonal b-actin (sc-47778, 1:500; Santa Cruz Biotechnology,
Inc., Santa Cruz, CA, USA). Immunoreactivity was detected with
horseradish peroxidase-conjugated goat anti-mouse (Santa Cruz)
or anti-rabbit (Bioworld Technology, Inc., St. Paul, MN, USA)
antibodies.
2.10. Northern blotting
The expression of mature miR-204 in RSC96 cells transfected
with miR-204 mimics and inhibitor was detected by northern blot-
ting. The 50 ends of the probes for miR-204 (AGG CAT AGG ATG ACA
AAG GGA A) and U6 snRNA (ATA TGG AAC GCT TCA CGA ATT) were
labeled with c-32P-ATP, and the assay was performed according to
a published protocol (http://bartellab.wi.mit.edu/protocols/small-
RNA northern.pdf).
2.11. Determination of viability and apoptosis
RSC96 cells were seeded in 96-well plates (4  103 cells/well),
and various concentrations of H2O2 (0, 0.025, 0.05, 0.1, 0.2, 0.5,
0.8, 1.0, 1.2, or 1.5 mmol/l) were added to the wells (ﬁve replicates
each). The CellTiter 96 AQueous One Solution cell proliferation
assay (Promega) was used to determine the optimal H2O2 concen-
tration based on the number of viable cells. Terminal deoxynucleo-
tidyl transferase dUTP nick end labeling was performed on cells
treated with 0.1 mmol/l H2O2 and cotransfected with miR-204
mimics, miRNA negative control, pcDNA3.1-Nrn1 plasmid, or
pcDNA3.1(+) plasmid as a negative control using the DeadEnd
Colorimetric Apoptosis Detection System (Promega).
2.12. Statistical analysis
Data are shown as the mean ± S.D. Assays were performed in
triplicate and experiments were repeated three times. Means were
compared using the Student–Newman–Keuls test, and P < 0.05 was
considered statistically signiﬁcant.
3. Results
3.1. Identiﬁcation of putative miRNAs interacting with Nrn1
MiRNAs that potentially regulate Nrn1 expression were identi-
ﬁed by bioinformatics approaches using a 990-base pair 30UTR
fragment of the rat Nrn1 mRNA sequence (NCBI accession number
BC087582) and 728 mature rat miRNA sequences downloaded
from miRBase (release 20). To maximize accuracy, miRanda, Pictar,
and TargetScan were applied to the prediction of the miRNA-Nrn1
interaction. A total of 67 miRNAs potentially binding to the Nrn130UTR were identiﬁed. After the following conditions were
applied—a miRanda score > 95, 61 base mismatched with the seed
sequence, and binding free energy < 20 kcal/mol—20 candidate
miRNAs were retained (Supplementary Table 1).
3.2. Identiﬁcation of miRNAs differentially expressed in the
hippocampus in TGI
In the TGI model, brain regions such as the hippocampus that
are sensitive to ischemia had a high rate of neuronal death [34].
Here, 338 mature miRNAs expressed in the hippocampus of rats
were detected using next-generation sequencing. Of these, 45
had over 10000 reads, including miRNAs of the let-7 family, and
miR-9, -124, -125–5p, and -128, which are highly expressed in
the mouse brain [35]. Moreover, 32 miRNAs were differentially
expressed between TGI and sham control animals, including 23
that were upregulated and nine that were downregulated in the
TGI group relative to controls (Supplementary Data 1).
3.3. Nrn1 30 UTR contains two conserved binding sites for miR-204
Only two miRNAs, miR-204 and -758, were identiﬁed by both
bioinformatics approaches and high throughput sequencing
(Table 1). The homology of the 30UTR fragment with the 2–8-nucle-
otide seed sequence of the miRNA 50 end is critical for miRNA
target recognition [36]. The homology analysis showed two
miR-204-binding sites in the Nrn1 30UTR that had high homology
in mammals, while the miR-758-binding sites had low homology
(Supplementary Fig. 1).
3.4. Nrn1 and miR-204 expression are inversely correlated
To assess whether miR-204 and -758 regulate Nrn1, their
expression proﬁles in the cortex and hippocampus were assessed
in the TGI model. Nrn1mRNA and protein expression was elevated
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that was especially pronounced in the hippocampus. Nrn1 protein
level was higher than in controls 3 days after TGI, reaching a peak
at 14 days before decreasing to the baseline level at 21 days. The
quantitative analysis showed that miR-204 and -758 levels were
reduced and elevated, respectively, after TGI (Fig. 1E and F), consis-
tent with the results of high throughput sequencing. Moreover, a
negative association was observed between Nrn1 and miR-204 in
the post-TGI time course of expression, implying that miR-204 acts
as a negative regulator of Nrn1 expression.
3.5. Nrn1 is a target of miR-204
To eliminate any effects of endogenous Nrn1 expression in the
luciferase reporter assay, RT-PCR was used to screen cell lines that
do not express Nrn1 and have high transfection efﬁciency. Nrn1
was highly expressed in RSC96 but not HeLa or SK-N-BE(2) cells
(Fig. 2A). HeLa cell line was therefore chosen for the luciferase
reporter assay.
To verify whether Nrn1 is a bona ﬁde target of miR-204, the
Nrn1 overexpression plasmid (Fig. 2B) was cotransfected with
miR-204 or -758 mimics or a negative control mimic into HeLa
cells that lack endogenous Nrn1. Both miRNAs effectively bound
their respective Nrn1 30UTR target sites in the recombinant
plasmid, as evidenced by a reduction in the expression of Renilla
luciferase (Fig. 2C).Fig. 1. Expression analysis of putative neuritin (Nrn)1 regulatory miRNAs. (A) Nrn1 protei
(in days, d) after induction of transient global ischemia and in sham controls; b-actin wa
normalized to level b-actin. (D) Hippocampus Nrn1 mRNA expression in rats was ass
expression of the microRNAs (E) miR-204 and (F) miR-758 in the hippocampus was eval
(B)–(F) are expressed as mean ± S.D.(n = 6). ⁄P < 0.05, ⁄⁄P < 0.01 vs. sham.To eliminate the possibility that these were falsely positive
results, the expression of miR-204 and -758 were artiﬁcially
manipulated using miRNA mimics and inhibitors, and by verifying
endogenous Nrn1 expression in RSC96 cells by RT-PCR, q-PCR and
immunoblotting. The miR-204 mimics enhanced the expression of
mature miR-204 in the cells, while the miR-204 inhibitor sup-
pressed miR-204 expression to an undetectable level (Fig. 3A).
These results indicated miRNA mimics and inhibitor could be used
to up- or downregulate miRNA levels in RSC96 cells. The Nrn1 tran-
script level declined upon transfection of the miR-204 mimic
(Fig. 3B and C), but the reduction was minimal when the miR-
758 mimic was used. Similar effects were observed for Nrn1 pro-
tein expression (Fig. 3D–F), suggesting that miR-204 inhibits
Nrn1 mRNA and consequently, protein expression by binding to
the 30 UTR.
3.6. MiR-204 promotes apoptosis in Schwann cells by suppressing
Nrn1 expression during oxidative stress
The oxidative stress response causes necrosis in neurons but
also induces apoptosis by activating redox signaling, which is a
principal cause of brain injury [37,38]. Various studies have shown
that Nrn1 can promote neuronal survival by inhibiting apoptosis,
thereby providing a repair mechanism after nervous system injury
[11,18–21,39]. Given the above ﬁndings, it was hypothesized that
Nrn1 expression during oxidative stress-induced nerve celln expression in the cerebral cortex and hippocampus of rats at indicated time points
s used as a loading control. (B) and (C) Quantiﬁcation of expression data show in (A)
essed by quantitative real-time (RT)-PCR normalized to the level of b-actin. The
uated by quantitative RT-PCR relative to the level of U6 small nuclear RNA. Data in
AB
C
Fig. 2. Evaluation of potential interactions between microRNAs (miR) and neuritin (Nrn)1 with the luciferase reporter assay. (A) Nrn1mRNA expression was assessed by RT-
PCR in RSC96, HeLa and SK-N-BE(2) cells in which endogenous Nrn1 expression is present and absent, respectively. (B) Schematic representation of the Renilla (hRluc) and
ﬁreﬂy (hFluc) luciferase expression vector and the 30 untranslated region (UTR) of the Nrn1 transcript. (C) Luminescence ratios in HeLa cells cotransfected with the dual
luciferase reporter and mimics for miR-204 or -758, or negative control (NC) mimic. Data are expressed as mean ± S.D. (n = 3). ⁄⁄P < 0.01 vs. cells cotransfected with Nrn1
30UTR and NC mimic.
A B
C D
E F
Fig. 3. Effect of altered miRNAs expression on neuritin (Nrn)1 mRNA and protein levels. (A) Northern blot of RSC96 Schwann cell lysates upon expression of miR-204 mimics
or inhibitor, or a negative control (NC) mimic. U6 small nuclear (sn)RNA expression was used as a positive control. (B) Nrn1 mRNA expression in cells in which miR-204 or -
758 was up-or downregulated was evaluated relative to GAPDH expression. Expression of Nrn1 (C) mRNA and (D) protein was evaluated in cells under different treatment
conditions by RT-PCR and immunoblotting (with b-actin used as a loading control), respectively. (E) Quantiﬁcation of expression data shown in (C) and (D) normalized to
levels of GAPDH and b-actin, respectively. Data in (B), (E), and (F) are expressed as mean ± S.D. (n = 3). ⁄P < 0.05, ⁄⁄P < 0.01 vs. control (blank) or NC mimics.
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Fig. 4. Effect of microRNA miR-204 on oxidative stress-induced apoptosis. (A) RSC96 Scwhann cells were exposed to a range of H2O2 concentrations to determine the median
lethal dose. (B) Terminal deoxynucleotidyl transferase dUTP nick end labeling was used to detect apoptosis under the following treatment conditions: a, blank control; b,
0.1 mmol/l H2O2; c, 0.1 mmol/l H2O2 and miR-204 mimics; d, 0.1 mmol/l H2O2 and miR-204 mimics; e, 0.1 mmol/l H2O2 and pcDNA-Nrn1 plasmid; and f, 0.1 mmol/l H2O2 and
pcDNA3.1(+) empty plasmid. (C) Rate of apoptosis was calculated as rate = apoptotic cell number/total cell number from three images taken for each treatment condition,
including miR-204 overexpression (mimic), negative control (NC mimic), neuritin (Nrn)1 overexpression (pcDNA-Nrn1), or negative control [empty backbone vector
pcDNA3.1(+)] in the presence of H2O2. Different lowercase letters in (C) between any two groups indicate signiﬁcant differences (n = 3; P < 0.01). (D) Expression of Nrn1 and
the apoptotic factor cleaved caspase 3 was assessed under the various treatment conditions by Western blotting, with b-actin used as a loading control. (E) and (F)
Quantiﬁcation of expression data shown in (D) normalized to level b-actin, respectively. Data in (E) and (F) are expressed as mean ± S.D. (n = 3). ⁄P < 0.05, ⁄⁄P < 0.01 vs. control
(blank) or H2O2 groups.
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was induced in RSC96 cells by treatment with the optimal median
lethal H2O2 concentration of 0.1 mmol/l (Fig. 4A). At this concen-
tration, the number of apoptotic cells—as well as the expression
of the apoptotic kinase cleaved caspase-3—was higher than
untreated control cells (P < 0.01) (Fig. 4B and C). These results dem-
onstrated that a model of oxidative stress-induced apoptosis could
be achieved by treating RSC96 cells with 0.1 mmol/l H2O2 for 24 h,
which was used to test the role of miR-204. The rate of apoptosis
was higher in H2O2-treated cells transfected with miR-204 than
in control cells treated with H2O2. In contrast, the rate of apoptosis
was lower in H2O2-treated cells overexpressing Nrn1 than in H2O2-
treated control cells (Fig. 4B and C). Thus, the presence of miR-204
enhanced the sensitivity of RSC96 cells to oxidative stress and
accelerated apoptosis, while the overexpression of Nrn1 sup-
pressed oxidative stress-induced apoptosis, and hence promoted
cell survival.
Nrn1 protein expression in RSC96 cells declined after transfec-
tion of miR-204 mimics in conjunction with 0.1 mmol/L H2O2
treatment (Fig. 4D–F), while the cleaved caspase-3 level increased.
In contrast, in cells overexpressing Nrn1, the cleaved caspase-3
level decreased concomitantly with the increase in Nrn1 level.These results suggest that miR-204 modulates the sensitivity of
RSC96 cells to oxidative stress and consequent apoptosis through
post-transcriptional inhibition of the target gene Nrn1.
4. Discussion
There is mounting evidence of the key role of miRNAs in the
transcriptional and post-transcriptional regulation of gene expres-
sion in biological processes. In the present study, the time course of
miR-204 and Nrn1 expression in the rat hippocampus after TGI
were inversely associated, suggesting that Nrn1 expression was
under the negative regulatory control of miR-204 (Fig. 1). Indeed,
in vitro assays showed that miR-204 bound speciﬁc sites in the
30UTR of the Nrn1 transcript, conﬁrming its identity as a target
gene of miR-204 (Figs. 2 and 3).
MiR-204 is implicated in multiple cellular functions through its
regulatory role in the expression of various target genes [40–44].
For instance, sympathetic neuron terminals express a high level
of miR-204, suggesting an important role in the maintenance of
axonal structure and function as well as neuronal growth and
development [45]. MiR-204 expression is induced in the mouse
retina by light stimulus, suggesting that it is involved in adaption
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expression of the targeted tyrosine kinase receptor NTRK2/TrkB
of BDNF [47]. Interestingly, Nrn1 expression in the rat cortex is also
induced by light [7] as well as by synaptic activity [12] and BDNF
[13]. Thus, miR-204 and Nrn1 are similarly induced and are associ-
ated with the growth and development of neurites, supporting the
possibility of their direct interaction in vivo. Moreover, an upregu-
lation of Nrn1 expression is observed in Kaposi’s sarcoma [48],
breast cancer [49], and astrocytomas [50], while miR-204 expres-
sion is reduced in several types of tumor [40–42], suggesting that
loss of miR-204 is associated with tumorigenesis. The present ﬁnd-
ing that miR-204 negatively regulates Nrn1 expression suggests
that tumor development, and tumor cell survival and apoptosis
could be mediated by of the control of Nrn1 by miR-204.
Ischemic brain injury can arise from oxidative stress, inﬂamma-
tion, and excitotoxicity. During oxidative stress, oxygen free
radicals cause peroxidation of proteins, lipids, and nucleic acids,
resulting in protein inactivation and denaturation, membrane
phospholipid hydrolysis, and breaks in the nucleic acid backbone,
ultimately leading to irreversible nerve cell death [51,52].
Intermediate levels of free radicals during mild cerebral ischemia
can induce apoptosis by activating themitochondrial [53,54], endo-
plasmic reticulum [55], membrane receptor, or DNA repair enzyme
pathways [56,57]; high levels of free radicals can stimulate the
release of excitatory neurotransmitters that lead to nerve damage,
and can aggravate reperfusion injury by activating the expression
of cytokines and adhesion molecules that mediate inﬂammation
and the immune response, respectively [51].
Recovery is more difﬁcult from CNS than from PNS injury, and it
has been suggested that the absence of Schwann cells in the CNS is
one reason for this difference. In fact, Schwann cells can differenti-
ate from oligodendrocyte precursors in the CNS [4,5], although
their capacity for proliferation—and thus for repair—is limited by
the presence of astrocytes. Transplanting neurotrophin-modiﬁed
Schwann cells in the CNS has shown promising results in terms
of enhancing the capacity for repair by Schwann cells following
CNS injury. In the present study, the sensitivity of RSC96 cells to
oxidative stress was enhanced by suppression of Nrn1 expression,
while overexpression of miR-204 induced apoptosis of Schwann
cells and expression of cleaved caspase 3. In HTM cells under oxi-
dative stress, miR-204 overexpression led to increased apoptosis
via targeted regulation of the anti-apoptotic proteins Bcl-w and
cIAP1 [42], indicating that miR-204 regulates the expression of
multiple anti-apoptotic proteins [44]. The present ﬁndings reveal
a novel mechanism of Nrn1 gene regulation by a miRNA in
Schwann cells that can potentially be exploited to promote self-
repair by injured nerves.
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